Biography

Dr. Ziyan Pan is a Lecturer at the Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney. He completed his PhD in Medicine at the University of Sydney in 2024, under the supervision of Mohammed Eslam, following a Master of Biomedical Science from The University of Western Australia (2019) and a Bachelor of Biological Science from Northwest Normal University, China (2017).

Dr. Pan’s research focuses on: Fibrotic diseases: identifying and characterizing novel pathways and therapeutic targets; Genetic Risk and MAFLD: elucidating the functional mechanisms underlying genetic risk variants associated with MAFLD; Lean MAFLD Profile and Pathophysiology: characterizing the distinct metabolic and histological profiles of Lean MAFLD and exploring associated mortality factors.

Dr. Pan has over 45 publications and one book chapter within the past five years, including papers in Science Translational Medicine, Nature Communications, Metabolism, and Journal of Hepatology. He also serves as a co-supervisor to PhD students and visiting scholars.

Dr. Pan has received continued 3 successful Westmead Institute Scientific Excellence (WISE) awards since 2023. He is an invited reviewer for several journals, including the Journal of Clinical and Translational Hepatology, Scientific Reports, and PLOS ONE, and is a member of the Editorial Review Board for Therapeutic Advances in Endocrinology and Metabolism and Metabolism and Target Organ.

Adjunct roles

Additional information

Projects

• Selective therapeutic targeting of fatty liver disease and related fibrosis
• Switching splicing to treat fatty liver disease and related fibrosis
• Metabolic adaptation in Lean-MAFLD
• Selective therapeutic targeting of pan-organ fibrosis

Awards and recognition